Gregor Heitzinger

MD, PhD

[Suriya Prausmüller @prausmuller]

Last evening at #ESC2025 in Madrid 🇪🇸 – reflecting on an successful congress full of knowledge, exchange, and great discussions.
It was a pleasure to meet Prof. Seferović and take a photo together. 📸

#ESC2025 #Madrid #Cardiology #MedicalConference #heartfailure #MedUniVienna

[EACVI President @EACVIPresident]

🔴 #EACVI Summit 2025 – 10th Edition | Valencia, Spain 🇪🇸

The European Association of Cardiovascular Imaging is proud to host the 10th edition of the #EACVI Summit with National Societies on 29–30 May 2025 in Valencia.

Since 2009, this biennial summit has served as a vital platform to strengthen collaboration between #EACVI and our National Cardiac Societies (NCS) across the 57 ESC member countries.

This year, we introduce a new, forward-thinking format designed to:
🔹 Enhance shared strategy
🔹 Stimulate fresh ideas in education (MCQ books, simulation tools)
🔹 Support new proposals (e.g., MMI Congress, technologist tracks)

The 2025 Summit brings together:
✔️ 20 #EACVI Board Members
✔️ 36 NCS Representatives
✔️ 10 #HIT Ambassadors
✔️ 13 Industry Representatives
✔️ 83 participants from 33 countries

We believe in the power of dialogue, diversity, and innovation—and we are excited to continue shaping the future of #CVImaging through united efforts.

@VDelgadoGarcia @denisamuraru @s_e_petersen @gpontone1 @NAjmoneMarsan @RiccardoLiga7 @rmanka_ @carpenter_jp @anatimoteo46040 @Ph_Bertrand @Matte_Cameli @DrGEMandoli @Sarah_Moharem

[MedUni Wien @MedUni_Wien]

Patient:innen zu mehr Gesundheit zu verhelfen und in einem gut eingespielten Team zu arbeiten, das freut @g_heitzinger besonders. Lesen Sie mehr über die Studie unseres #ResearcheroftheMonth zur sekundären Trikuspidalklappeninsuffizienz. ➡ https://t.co/tkc6V3qLeV

[Gregor Heitzinger @g_heitzinger]

@RAULMACIAS23 @iamritu @BhaskarArora_MD @ASE360 @OHSUCardFellows @Mitrovalvology @GarySHuang @Drbernardourru1 doi: 10.1016/j.jacc.2019.02.075. There you go!

[EHJCVI Editor-in-Chief @EHJCVIEiC]

In secondary #tricuspid regurgitation (STR), high comorbidity burden is common and complicates patient management.

New study in #EHJCVI using #MachineLearning validated the most powerful predictors of all-cause mortality in #heartfailure pts with STR 🧵

https://t.co/TX9yhTdra7

[Denisa Muraru @denisamuraru]

Advancing our risk stratification of patients with tricuspid regurgitation using the most relevant markers of increased mortality.
Congratulations to @g_heitzinger @ggoliasch @pe_bartko for this elegant study using #MachineLearning in #EHJCVI

https://t.co/A2cpEF7nyI

@GeraldMaurer @alessia_gimelli @EACVIPresident @VDelgadoGarcia @Cosyns @lpbadano @drmaisano @FabienPraz @DonalErwan @hahn_rt

#EACVI #echofirst #cvimaging #CardioEd #CardioTwitter

[Henrike Arfsten @h_arfsten]

Secondary TR in HF:
☝️Prognostic significance across the spectrum of HF.
☝️Consider the systemic implication of sTR!
🤔What do we know about the RV pre- & after-load interplay in regard to #sTR treatment

@escardio @HeartFailure2023 @ESC_HFA @ValveDisease @MariannaAdamo1 @JMascherbauer

[JACC Journals @JACCJournals]

How are LV filling pressures affected by #CTEPH? How does this affect patient outcomes?

In this insightful work, Drs. @ChristianGerges, Lang, & colleagues evaluate this question w/ important implications for #CardioTwttier & #PulmTwitter providers: https://t.co/gm2cWiSFaq #JACC

[Konstantin Krychtiuk @krychtiukmd]

Had a lot of fun writing this with @ClemensGangl -

Digital Health - High Tech or High Touch?

#DigitalHealth #DigitalMedicine #EHealth #AI #machinelearning #CardioTwitter

[Meine Herzklappe @MHerzklappe]

Einen herzlichen Dank an Dr. Gregor Heitzinger @meduniwien @KardiologieWien für den informativen Vortrag über die Funktion der Herzklappen und die häufigsten Herzklappenerkrankungen.

Rechtzeitig erkannt sind sie gut behandelbar, deshalb ist es wichtig, die Symptome zu kennen‼️

[Jutta Bergler-Klein @BerglerKlein]

@KardiologieWien @MedUni_Wien @escardio @krychtiukmd @CHengstenbergMD @ValveDisease @pe_bartko @noemi_pavo @billrothhaus @wien_wissen @ICOSociety @Uro_MedUniWien @aekwien Thank you, Siva!

[Kardiologie MedUni Wien Forschung @KardiologieWien]

We congratulate @BerglerKlein from our @KardiologieWien @MedUni_Wien for her important role within the @escardio task force for #CardioOncology and the composition of the 2022 #guidelines presented at the world leading Cardiology Congress #ESCCongress

https://t.co/2v8TnC9stO

[Christian Nitsche @MdNitsche]

Dual pathology cardiac amyloidosis and mitral regurgitation is frequent and carries worse outcomes following mitral valve repair
@amyloidosis @mitral @g_heitzinger @pe_bartko @a_kammerlander @m_koschutnik @JMascherbauer @KardiologieWien

AddThis | Home https://t.co/2rilLSsJMy

[Kardiologie MedUni Wien Forschung @KardiologieWien]

Im Rahmen der Langen Nacht der Forschung können Sie eine von unseren @KardiologieWien ExpertInnen live-kommentierte minimal-invasive Herklappen-Implantation verfolgen!

Fr 20.5. 18:00
@MedUni_Wien / AKH Hörsaalzentrum

https://t.co/dHo4L9skJd

[Kardiologie MedUni Wien Forschung @KardiologieWien]

In a #whyCMR analysis, Rene Rettl and coworkers from @MedUni_Wien showed that treatment with tafamidis delays myocardial amyloid progression in ATTR-CM patients.

#amyloidosis #Cardiotwitter

https://t.co/FIuuGfQJc0

[JACC Journals @JACCJournals]

Topological mapping in secondary MR (sMR): #echofirst analysis shows importance of role of LA. Highest mortality in “small LV cavity” cluster. https://t.co/p71Eta3txG

#vhdMR #cvVHD #JACCIMG #CardioTwitter #cvImaging #HFrEF @ValveDisease @pe_bartko @g_heitzinger @ggoliasch

[Kardiologie MedUni Wien Forschung @KardiologieWien]

What are the key morphological and functional features in secondary mitral regurgitation?

@pe_bartko, @g_heitzinger, @ggoliasch et al from our @ValveDisease group present exciting novel data in @JACCJournals

https://t.co/JZG0CROvaB

[MedUni Wien @MedUni_Wien]

Häufig unterschätzt: #Mitralklappeninsuffizienz. Eine Studie der #MedUniWien und des #AKHWien erforscht neue Therapiemöglichkeiten von RisikopatientInnen mit Herzklappenfehlern: https://t.co/Doo4Il1siH

[The BMJ @bmj_latest]

"Valve repair strategies are rarely used across the entire heart failure spectrum with severe mitral regurgitation despite availability of minimal invasive and low risk options."

New #BMJResearch by @ggoliasch and colleagues
https://t.co/zJzbslP3Kf

[Structural Heart Vienna @ValveDisease]

Secondray #mitralregurgitation is prevalent across the heart failure spectrum! 📈
- 10% overall severe MR among #heartfailure patients🏥
- prevalence: #HFrEF> #HFmrEF > #HFpEF!
- poor prognosis☠️ in any #HF subtype!

https://t.co/VqLsTHckmq